Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to treating MASH, obesity, and associated cardiometabolic diseases, announced the appointment of Jorge Bartolome as Chief...
Deep Apple Therapeutics, announced a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop and commercialize oral small molecule therapies...
